// App-Quantinova.ai

e17043 : Real-world associations between bone-targeted agents and palliative bone radiotherapy in prostate cancer decedents A province-wide population study.

Researchers

Presenter

  • William James Phillips

Principal Investigators

  • Alborz Jooya

  • Roshanak Mahdavi

  • Jennifer Leigh

  • Karine Tawagi

  • Colleen Webber

  • Christina Milani

  • Scott Carlyle Morgan

  • Robert Malcolm MacRae

  • Jean-Marc Bourque

  • Peter Tanuseputro

  • Michael Ong

Medical Centers

  • Medical Oncology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

  • University of Ottawa, Ottawa, ON, Canada

  • Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada

  • The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

  • Division of Radiation Oncology, The University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada

  • Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Urology

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Zoledronic acid

  • Enzalutamide

  • Cabazitaxel

  • CB-7598

  • Radium-223 Dichloride

  • Docetaxel

  • Denosumab

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved